Literature DB >> 12506025

The PML gene is not involved in the regulation of MHC class I expression in human cell lines.

Silvia Bruno1, Fabio Ghiotto, Franco Fais, Marta Fagioli, Lucilla Luzi, Pier Giuseppe Pelicci, Carlo Enrico Grossi, Ermanno Ciccone.   

Abstract

The promyelocytic leukemia gene, PML, is a growth and transformation suppressor. An additional role for PML as a regulator of major histocompatibility complex (MHC) class I antigen presentation has been proposed in a murine model, which would account for evasion from host immunity of tumors bearing malfunctioning PML, such as acute promyelocytic leukemia. Here we investigated a possible role of PML for the control MHC class I expression in human cells. PML function was perturbed in human cell lines either by PML/RAR alpha transfection or by PML- specific RNA interference. Impairment of wild-type PML function was proved by a microspeckled disassembly of nuclear bodies (NBs), where the protein is normally localized, or by their complete disappearance. However, no MHC class I down-regulation was observed in both instances. We next constructed a PML mutant, PML mut ex3, that is a human homolog of the murine PML mutant, truncated in exon 3, that was shown to down-regulate murine MHC class I. PML mut ex3 transfected in human cell lines exerted a dominant-negative effect since no PML molecules were detected in NBs but, instead, in perinuclear and cytoplasmic larger dot-like structures. Nevertheless, no down-regulation of MHC class I expression was evident. Moreover, neither transfection with PML mut ex3 nor PML-specific RNA interference affected the ability of gamma-interferon to up-regulate MHC class I expression. We conclude that, in human cell lines, PML is not involved directly in the regulation of MHC class I expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12506025     DOI: 10.1182/blood-2002-11-3335

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Identification of E2F1 as an important transcription factor for the regulation of tapasin expression.

Authors:  Juergen Bukur; Felix Herrmann; Diana Handke; Christian Recktenwald; Barbara Seliger
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

Review 2.  Emerging Role of PML Nuclear Bodies in Innate Immune Signaling.

Authors:  Myriam Scherer; Thomas Stamminger
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

3.  Gamma interferon-dependent transcriptional memory via relocalization of a gene locus to PML nuclear bodies.

Authors:  Manolis Gialitakis; Panagiota Arampatzi; Takis Makatounakis; Joseph Papamatheakis
Journal:  Mol Cell Biol       Date:  2010-02-01       Impact factor: 4.272

Review 4.  Pondering the puzzle of PML (promyelocytic leukemia) nuclear bodies: can we fit the pieces together using an RNA regulon?

Authors:  Katherine L B Borden
Journal:  Biochim Biophys Acta       Date:  2008-06-18

5.  Characterization of Recombinant Human Cytomegaloviruses Encoding IE1 Mutants L174P and 1-382 Reveals that Viral Targeting of PML Bodies Perturbs both Intrinsic and Innate Immune Responses.

Authors:  Myriam Scherer; Victoria Otto; Joachim D Stump; Stefan Klingl; Regina Müller; Nina Reuter; Yves A Muller; Heinrich Sticht; Thomas Stamminger
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

6.  Functional connection between Rad51 and PML in homology-directed repair.

Authors:  Sergei Boichuk; Liang Hu; Kathleen Makielski; Pier Paolo Pandolfi; Ole V Gjoerup
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

7.  Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions.

Authors:  Jayson Wang; Carol Shiels; Peter Sasieni; Pei Jun Wu; Suhail A Islam; Paul S Freemont; Denise Sheer
Journal:  J Cell Biol       Date:  2004-02-16       Impact factor: 10.539

8.  Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus.

Authors:  Young-Eui Kim; Jin-Hyun Ahn
Journal:  PLoS Pathog       Date:  2015-03-26       Impact factor: 6.823

9.  A role for cytoplasmic PML in cellular resistance to viral infection.

Authors:  Beth A McNally; Joanne Trgovcich; Gerd G Maul; Yang Liu; Pan Zheng
Journal:  PLoS One       Date:  2008-05-28       Impact factor: 3.240

Review 10.  Therapeutic opportunities of small interfering RNA.

Authors:  Bhoomika R Goyal; Mayur M Patel; Mithil K Soni; Shraddha V Bhadada
Journal:  Fundam Clin Pharmacol       Date:  2009-08       Impact factor: 2.748

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.